Biotech

All Articles

FDA scraps adcomm for Applied's uncommon illness drug

.After pushing the decision meeting for Applied Therapeutics' metabolic ailment drug govorestat, the...

Novo inks $600M NanoVation deal to study hereditary medications ex-liver

.Novo Nordisk is actually continuing its press right into hereditary medications, consenting to comp...

Innovent links cytokine to colon cancer cells actions

.Innovent Biologics has created the instance that its checkpoint inhibitor-cytokine blend protein ha...

Merck, Daiichi ADC hits target in stage 3 bronchi cancer research study

.A phase 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens artificial intelligence focus with collab to pick cancer intendeds

.Five months after Rakovina Rehabs pivoted toward expert system, the cancer-focused biotech has actu...

Ascendis' dwarfism drug hits in stage 3, intimidates BioMarin

.Ascendis Pharma has emerged as a possible danger to BioMarin's Voxzogo, mentioning phase 3 developm...

Despite ph. 3 miss, Alkeus observes road in advance for eye condition asset

.Though Alkeus Pharmaceuticals' dental eye disease resource stopped working to substantially minimiz...

Kairos goes public with $6M IPO to cash tests of cancer cells drug

.With a triad of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to miss out o...

Vaccine and Keytruda combination reliable in squamous cell carcinoma

.Immune gate preventions are actually the superheroes of cancer therapy. Medicines like Bristol Myer...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable management hirings, shootings and als...